- Download William Demant Holding A/s Driver Download
- Download William Demant Holding A/s Driver Download
- William Demant Holding Stock
Type | |
---|---|
Nasdaq Copenhagen: WDH | |
Industry | Health care |
Founded | 1904 |
Headquarters | Smørum, Denmark |
Key people | Niels B. Christiansen (Chairman), Søren Nielsen (President and CEO) |
Products | Hearing aids, audiometric equipment |
Revenue | DKK 13.189 billion (2017) |
DKK 2.338 billion (2017) | |
DKK 1.759 billion (2017) | |
Total assets | DKK 16.222 billion (end 2017) |
Total equity | DKK 7.433 billion (end 2017) |
13280 (average, 2017) | |
Subsidiaries | Oticon |
Website | www.demant.com |
Demant A/S is a leading international hearinghealth care company within hearing aids, audiometric equipment, and personal communication.
Enue in 2015 of 16%. William Demant Holding A/S continues to be William Demant Invest A/S’ largest investment account-ing for approximately 76% of pro forma revenue2. The growth in pro forma revenue was mainly driven by a reported 14% growth in William Demant Holding A/S and, when translated. William Demant Invest A/S, a company wholly owned by William Demant Foundation, holds the majority of the shares in Demant A/S, providing stability and strength for the future. A copy of Demant’s annual report for 2019 can be found online at.
Beginning[edit]
The Demant Group was founded in 1904 by Hans Demant, under the name Oticon. After his death in 1910, his son William Demant took over.
- Dec 19, 2020 COVID 19 Impact Analysis of Global Audiological Devices Market Report 2020 Auditdata, Cochlear Limited, GN ReSound A/S, Med-EL Medical Electronics, Natus Medical Incorporated, Sonova Holding AG, Advanced Bionics Corporation, Phonak AG, Sivantos Group, Starkey Hearing Technologies, Widex A/S, William Demant Holding A/S, Bernafon AG, Oticon Medical, Sonic Innovations Inc., Oticon A/S.
- “1.1 The Company’s name is Demant A/S. 1.2 The Company’s secondary names are William Demant Holding A/S and Oticon Holding A/S.” Re agenda item 7d The Board of Directors proposes that a revised Remuneration Policy and General Guidelines on Incentive Pay be.
- The Demant Group operates in a global market with companies in more than 30 countries, employs more than 16,000 employees and generates an annual revenue of DKK 14.5 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.
Already before World War I, Oticon increased its sales volume to cover Scandinavia and Saint Petersburg. In the twenties and thirties, a network of agents was established in Europe.
During World War II, Oticon started its own production due to the scarcity of goods from other countries.
In 1957, William and his wife Ida Emilie donated the Demant family's shares in the company to the Oticon Foundation which is today called The William Demant Foundation. The Foundation's general aim is charity with particular emphasis on helping people with a hearing impairment and today the Oticon Foundation is the main shareholder in William Demant Holding A/S with a holding of app. 61%.
International expansion[edit]
During the 1990s the company expanded further, buying the Swiss hearing aid manufacturer Bernafon, Phonic Ear, the headset manufacturer DanaCom and Interacoustics.
In 1995 the company was listed at the Copenhagen Stock Exchange.
In 1997 it was decided to change the name of the parent company from Oticon Holding A/S to William Demant Holding A/S because it was considered disadvantageous to use the same name, both for the Group, and for one of its businesses. Further in 2019 William Demant Holding A/S changed its name to Demant A/S
In February 2017 it was announced that former President & CEO Niels Jacobsen would step down after 25 years in charge of the company. Instead he would become CEO of William Demant Invest A/S
Since 1 April 2017 the company is led by President & CEO, Søren Nielsen and board chairman Niels B. Christiansen.
Download William Demant Holding A/s Driver Download
Today the company focuses on three separate business units:
- Hearing Aids
- Oticon, Bernafon, Sonic Innovations, Neurelec (cochlear implants) and Oticon Medical (Bone anchored hearing aids)
- Diagnostic Instruments
- Maico Diagnostics, Interacoustics, Amplivox, Grason-Stadler, and MedRx, Inc.
- Personal Communication
- Phonic Ear, Sennheiser Communications
- Instrument Dealers
- Gordon Stowe & Associates Inc., Northeastern Technologies Group Inc., Midlantic Technologies Group Inc.
References[edit]
External links[edit]
Download William Demant Holding A/s Driver Download
William Demant Holding Stock
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $224.806B | 34.75 |
Medtronic (MDT) | Ireland | $159.800B | 32.44 |
Stryker (SYK) | United States | $92.196B | 33.02 |
Boston Scientific (BSX) | United States | $55.659B | 40.49 |
Lonza Group Ag (LZAGY) | Switzerland | $50.490B | 0.00 |
Baxter (BAX) | United States | $39.772B | 25.20 |
EssilorLuxottica (ESLOY) | France | $35.128B | 0.00 |
Zimmer Biomet Holdings (ZBH) | United States | $33.623B | 28.61 |
Terumo (TRUMY) | Japan | $33.381B | 50.52 |
Sunny Optical Technology (SNPTF) | China | $31.584B | 0.00 |
ResMed (RMD) | United States | $29.179B | 37.84 |
Bio-Rad Laboratories (BIO) | United States | $19.205B | 61.14 |
Smith & Nephew SNATS (SNN) | United Kingdom | $19.039B | 0.00 |
Insulet (PODD) | United States | $18.929B | 652.52 |
Canopy Growth (CGC) | Canada | $15.229B | 0.00 |
GN STORE NORD (GNNDY) | Denmark | $12.093B | 56.04 |
DiaSorin S.p.A (DSRLF) | Italy | $12.037B | 0.00 |
Quidel (QDEL) | United States | $9.652B | 24.05 |
Shandong Weigao Medical Polymer (SHWGF) | China | $8.999B | 0.00 |
Hill-Rom Holdings (HRC) | United States | $7.175B | 18.23 |
Haemonetics (HAE) | United States | $6.902B | 52.64 |
GW Pharmaceuticals (GWPH) | United Kingdom | $6.666B | 0.00 |
TG Therapeutics (TGTX) | United States | $6.418B | 0.00 |
Envista Holdings (NVST) | United States | $6.351B | 41.01 |
Perrigo (PRGO) | Ireland | $6.249B | 11.01 |
Maravai LifeSciences Holdings (MRVI) | United States | $5.773B | 0.00 |
Aphria (APHA) | Canada | $5.347B | 0.00 |
Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.870B | 0.00 |
Neogen (NEOG) | United States | $4.647B | 76.56 |
ICU Medical (ICUI) | United States | $4.574B | 34.33 |
National Vision Holdings (EYE) | United States | $4.149B | 108.96 |
Agios Pharmaceuticals (AGIO) | United States | $3.985B | 0.00 |
NanoString Technologies (NSTG) | United States | $3.442B | 0.00 |
AdaptHealth (AHCO) | United States | $3.292B | 156.41 |
NuVasive (NUVA) | United States | $3.008B | 43.44 |
Quanterix (QTRX) | United States | $2.901B | 0.00 |
AtriCure (ATRC) | United States | $2.895B | 0.00 |
InMode (INMD) | Israel | $2.151B | 37.79 |
Aurora Cannabis (ACB) | Canada | $2.051B | 0.00 |
Owens & Minor (OMI) | United States | $2.010B | 21.19 |
Cardiovascular Systems (CSII) | United States | $1.736B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.361B | 1386.33 |
Veru (VERU) | United States | $1.354B | 0.00 |
Omeros (OMER) | United States | $1.340B | 0.00 |
Lantheus Holdings (LNTH) | United States | $1.337B | 23.80 |
Meridian Bioscience (VIVO) | United States | $1.290B | 18.45 |
Cerus (CERS) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $1.170B | 0.00 |
PetIQ (PETQ) | United States | $1.037B | 59.21 |
OraSure Technologies (OSUR) | United States | $0.990B | 0.00 |
BellRing Brands (BRBR) | United States | $0.970B | 36.72 |
LeMaitre Vascular (LMAT) | United States | $0.967B | 51.11 |
HEXO (HEXO) | Canada | $0.948B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.930B | 20.00 |
VAREX IMAGING (VREX) | United States | $0.911B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.852B | 0.00 |
Vapotherm (VAPO) | United States | $0.827B | 0.00 |
Surmodics (SRDX) | United States | $0.741B | 598.45 |
Zynex (ZYXI) | United States | $0.670B | 62.19 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.634B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.626B | 44.45 |
Chimerix (CMRX) | United States | $0.619B | 0.00 |
Cytosorbents (CTSO) | United States | $0.491B | 0.00 |
Surface Oncology (SURF) | United States | $0.464B | 0.00 |
InfuSystems Holdings (INFU) | United States | $0.393B | 55.54 |
Viemed Healthcare (VMD) | United States | $0.391B | 13.86 |
Neptune Wellness Solutions (NEPT) | Canada | $0.368B | 0.00 |
Apyx Medical (APYX) | United States | $0.351B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.332B | 31.11 |
Oramed Pharmaceuticals (ORMP) | United States | $0.300B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
Evolus (EOLS) | United States | $0.238B | 0.00 |
Exagen (XGN) | United States | $0.232B | 0.00 |
Green Organic Dutchman Holdings (TGODF) | Canada | $0.180B | 0.00 |
Akerna (KERN) | United States | $0.175B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.159B | 0.00 |
Chembio Diagnostics (CEMI) | United States | $0.144B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.125B | 0.00 |
Fonar (FONR) | United States | $0.118B | 17.22 |
Brainsway (BWAY) | Israel | $0.100B | 0.00 |
Nephros (NEPH) | United States | $0.084B | 0.00 |
ImmuCell (ICCC) | United States | $0.081B | 0.00 |
Glucose Health (GLUC) | United States | $0.066B | 0.00 |
United-Guardian (UG) | United States | $0.066B | 15.94 |
Global Wholehealth Partners (GWHP) | United States | $0.065B | 0.00 |
Myomo (MYO) | United States | $0.060B | 0.00 |
FSD PHARMA INC (HUGE) | Canada | $0.059B | 0.00 |
Stagezero Life Sciences (GNWSF) | Canada | $0.052B | 0.00 |
Akers Biosciences Inc (AKER) | United States | $0.033B | 0.00 |
BOQI Medical (BIMI) | China | $0.027B | 0.00 |
Histogen (HSTO) | United States | $0.021B | 0.00 |
NeuroMetrix (NURO) | United States | $0.016B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.000B | 11.20 |